APP

APP

AppLovin

Platform / Network

★ Quality 80/100
Overvalued

Price today

$413.76

what the market pays

Worth

$315.00

calculated cycle value

Worth $315.00price today $413.76

Price is 31% above its value

charlieapp.co

Price vs Intrinsic Value

VI$10.5$188$365$542$719'21'22'23'24'25'26APPVI $315 · MdS -24%
UndervaluedDiscountedFair priceIV = current model value

The line is the price month by month; the green band marks when it's undervalued (−20% off value). When the price drops in there, the discount is real, not opinion.

Where does the value come from?

🌐

Digital platform

$309.08

per share

How it's calculated

💰

Free cash flow per share

normalized free cash flow

$9.76
×
📐

Multiplier

years of discounted cash flows

29.0x
=
🏢

Business value

without cash

$309.08

AI-native ad-tech. Axon engine moat. Rev +70%, FCF 60% margin. SEC investigation active. PEG 0.71. WAIT for SEC clarity.

🏦

Net cash in the bank

cash minus financial debt, per share

+$5.92

Total calculated value

business + cash

$315.00

How many times the cash flow

Platform / Network · vs 27 peers

You pay today
41.8x
Sector median
26.1x
Charlie: worth
31.7x

You pay 41.8x times this business's cash flow; its sector median is 26.1x.

24% above what Charlie thinks it's worth (31.7x) — you're overpaying, sector or no sector.

Why Overvalued?

Its free cash flow is $9.76/share × 29.0x multiplier plus $5.92 in net cash = $315.00 in intrinsic value. Today's price of $413.76 is 24% above the calculated value — the market is paying a premium over what the model sees as fair.

⚠️

The price is 31% above the calculated value. You're paying more than it's worth.

⚠️

Buying here lowers your expected return and wipes out the safety margin.

💡

The next reasonable entry zone starts at $299.25.

At what price would buying make sense?

Entry zones

🟢 Undervalued

$252.00

-20% off Value

🟡 Discounted

$299.25

-5% off Value

🔴 Today

$413.76

-24% Valor

🔴

Overvalued

The market prices it too high versus what the business makes. Patience pays off here.

Time is the friend of the wonderful company, the enemy of the mediocre.

— Warren Buffett

Model updated · July 2026

The business

Axon is the AI auctioneer that charges for every ad served inside apps.

AppLovin runs Axon, an AI engine that connects advertisers with mobile apps via real-time bidding. It charges a commission on every impression served, with a 73% gross margin and a 60% FCF margin. The software segment already eclipses the legacy first-party gaming business.

Axon improves with every dollar spent: more data, better targeting, better ROAS (return on ad spend) for the advertiser. It's a data flywheel that's hard to replicate without equivalent scale. Even so, Meta and Google play the same game with more muscle.

Revenue history

$1.5B
2020
$2.8B
2021
$2.8B
2022
$3.3B
2023
$4.7B
2024
CAGR 5 años: +33%

From $1.5B to $4.7B in 4 years — nearly 3.1x its size. Selling more and more is the base of everything else.

Where each $100 of sales goes

Revenue $5.5B · FY2025

Cost of sales$665M · 12%
Operations$664M · 12%
Taxes and other$818M · 15%
Net profit$3.3B · 61%

Of every $100 in sales, $39 goes to costs and operations; $61 is left as net profit (61% margin).

Catalysts and risks

Resolution of the SEC investigation into attribution practices.

Divestiture of the Apps (gaming) business announced for 2025, ~$900M.

Axon expansion into e-commerce and CTV, a TAM 10x larger than mobile gaming.

⚠️

SEC investigation active over allegations of scraping Meta data.

⚠️

Concentration: ~70% of revenue comes from mobile gaming advertisers.

⚠️

Privacy changes from Apple (ATT) or Google can break attribution.

Charlie's note

An extraordinary business priced like one. The problem isn't the price, it's the SEC looking at the books. I'll sit in the stands until the referee speaks.

Analysis · May 2026

So when would be a good price for AppLovin?

By our calculation, not yet. We will email you the day it drops to $299.25 — so you do not have to keep checking.

🔔 Email me

Free · no card

Charlie informs, it doesn't advise. No information should be taken as a recommendation to buy or sell.